Literature DB >> 19890760

Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients.

Allison J Applebaum1, Michael W Otto, Mark A Richardson, Steven A Safren.   

Abstract

Neuropsychological (NP) impairment is multiply determined among HIV-infected and HIV-uninfected individuals who are also dually diagnosed with depression and who use illicit substances. The purpose of the present study was to assess the impact of HIV status, depression, and problematic substance use on NP performance. A total of 160 opiate-dependent outpatients undergoing methadone maintenance (80 HIV-infected, 80 HIV-uninfected) completed diagnostic and NP evaluations. Raw scores from individual NP tests were converted to Z scores relative to standard norms and were averaged to form a composite score. HIV-infected participants had significantly lower overall NP performance--as well as lower performance on tests of attention, motor speed, and verbal memory--than HIV-uninfected participants. In multiple regression analyses considering the role of depression and substance use, only HIV status emerged as a significant predictor of NP impairment. These findings confirm NP impairment in HIV-infected substance abusing patients independent of comorbid depression and severity of substance use.

Entities:  

Mesh:

Year:  2010        PMID: 19890760      PMCID: PMC3638786          DOI: 10.1080/13803390903313572

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  105 in total

1.  The neuropsychological test performance of drug-abusing patients: an examination of latent cognitive abilities and associated risk factors.

Authors:  William Fals-Stewart; Marsha E Bates
Journal:  Exp Clin Psychopharmacol       Date:  2003-02       Impact factor: 3.157

2.  Performance of patients with early HIV-1 infection on the Stroop Task.

Authors:  E M Martin; L C Robertson; H E Edelstein; W J Jagust; D J Sorensen; D San Giovanni; V A Chirurgi
Journal:  J Clin Exp Neuropsychol       Date:  1992-09       Impact factor: 2.475

3.  Effects of HIV seropositivity and drug abuse on cognitive function.

Authors:  M P Grassi; C Perin; F Clerici; C Zocchetti; M Borella; A Cargnel; A Mangoni
Journal:  Eur Neurol       Date:  1997       Impact factor: 1.710

4.  Verbal working memory storage and processing deficits in HIV-1 asymptomatic and symptomatic individuals.

Authors:  M K York; J J Franks; R R Henry; W J Hamilton
Journal:  Psychol Med       Date:  2001-10       Impact factor: 7.723

5.  Brain atrophy in HIV infection is more strongly associated with CDC clinical stage than with cognitive impairment.

Authors:  V Di Sclafani; R D Mackay; D J Meyerhoff; D Norman; M W Weiner; G Fein
Journal:  J Int Neuropsychol Soc       Date:  1997-05       Impact factor: 2.892

6.  A comparison of the trail making test, symbol digit modalities test, and the Hooper Visual Organization Test in an inpatient substance abuse population.

Authors:  R J McCaffrey; M M Krahula; R G Heimberg; K E Keller; M J Purcell
Journal:  Arch Clin Neuropsychol       Date:  1988       Impact factor: 2.813

7.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Authors:  Ned C Sacktor; Matthew Wong; Noeline Nakasujja; Richard L Skolasky; Ola A Selnes; Seggane Musisi; Kevin Robertson; Justin C McArthur; Allan Ronald; Elly Katabira
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

8.  Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity.

Authors:  Robert H Paul; Constantin T Yiannoutsos; Eric N Miller; Linda Chang; Christina M Marra; Giovanni Schifitto; Thomas Ernst; Elyse Singer; Todd Richards; G Jeffrey Jarvik; Richard Price; Dieter J Meyerhoff; Dennis Kolson; Ronald J Ellis; Gilberto Gonzalez; Robert E Lenkinski; Ronald A Cohen; Bradford A Navia
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

9.  HIV-associated prospective memory impairment increases risk of dependence in everyday functioning.

Authors:  Steven Paul Woods; Jennifer E Iudicello; Lisa M Moran; Catherine L Carey; Matthew S Dawson; Igor Grant
Journal:  Neuropsychology       Date:  2008-01       Impact factor: 3.295

10.  Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.

Authors:  Giovanni Schifitto; Bradford A Navia; Constantin T Yiannoutsos; Christina M Marra; Linda Chang; Thomas Ernst; Jeffrey G Jarvik; Eric N Miller; Elyse J Singer; Ronald J Ellis; Dennis L Kolson; David Simpson; Avindra Nath; Joseph Berger; Sharon L Shriver; Linda L Millar; Dodi Colquhoun; Robert Lenkinski; R Gilberto Gonzalez; Stuart A Lipton
Journal:  AIDS       Date:  2007-09-12       Impact factor: 4.177

View more
  10 in total

Review 1.  Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Authors:  Pria Anand; Sandra A Springer; Michael M Copenhaver; Frederick L Altice
Journal:  AIDS Behav       Date:  2010-12

2.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

3.  Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.

Authors:  Christina S Meade; Nina A Conn; Linda M Skalski; Steven A Safren
Journal:  J Behav Med       Date:  2010-09-21

4.  Methamphetamine Dysregulates Macrophage Functions and Autophagy to Mediate HIV Neuropathogenesis.

Authors:  John M Barbaro; Simone Sidoli; Ana Maria Cuervo; Joan W Berman
Journal:  Biomedicines       Date:  2022-05-27

Review 5.  Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.

Authors:  Matias Jaureguiberry-Bravo; Rebecca Wilson; Loreto Carvallo; Joan W Berman
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

6.  Prevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and Research.

Authors:  David E Vance
Journal:  ISRN Nurs       Date:  2013-02-03

7.  Cognitive Trajectory Phenotypes in Human Immunodeficiency Virus-Infected Patients.

Authors:  Raha M Dastgheyb; Ned Sacktor; Donald Franklin; Scott Letendre; Thomas Marcotte; Robert Heaton; Igor Grant; Justin C McArthur; Leah H Rubin; Norman J Haughey
Journal:  J Acquir Immune Defic Syndr       Date:  2019-09-01       Impact factor: 3.771

Review 8.  Is There Evidence for Neurocognitive Dysfunctions in Patients with Postnatal HIV Infection? A Review on the Cohort of Hemophilia Patients.

Authors:  Silvia Riva; Ilaria Cutica; Gabriella Pravettoni
Journal:  Front Hum Neurosci       Date:  2014-06-24       Impact factor: 3.169

Review 9.  Opioid and neuroHIV Comorbidity - Current and Future Perspectives.

Authors:  Sylvia Fitting; MaryPeace McRae; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-02       Impact factor: 4.147

10.  HIV Increases the Inhibitory Impact of Morphine and Antiretrovirals on Autophagy in Primary Human Macrophages: Contributions to Neuropathogenesis.

Authors:  John M Barbaro; Ana Maria Cuervo; Joan W Berman
Journal:  Cells       Date:  2021-08-24       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.